Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “LGMD2C”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Large-scale testing (Phase 3)WithdrawnNCT06952686
What this trial is testing

SRP-9005 in Limb Girdle Muscular Dystrophy Type 2C/R5 Pediatric and Adult Participants

Who this might be right for
Muscular Dystrophies, Limb-Girdle
Sarepta Therapeutics, Inc.
Not applicableUnknownNCT01740908
What this trial is testing

Stem Cell Quantification In Peripheral Blood After Hyperbaric Oxygen Therapy Treatments

Who this might be right for
Changes in Peripheral Blood Population Numbers and Type.
Restorix Research Institute, LLLP 8
Not applicableLooking for participantsNCT05989620
What this trial is testing

Long-Term Development of Muscular Dystrophy Outcome Assessments

Who this might be right for
LGMD1BLGMD1CLGMD1D+26 more
Virginia Commonwealth University 1,000
Early research (Phase 1)Study completedNCT01344798
What this trial is testing

Clinical Study of AAV1-gamma-sarcoglycan Gene Therapy for Limb Girdle Muscular Dystrophy Type 2C

Who this might be right for
Limb Girdle Muscular Dystrophy Type 2CGamma-sarcoglycanopathy
Genethon 9
Large-scale testing (Phase 3)Study completedNCT01035983
What this trial is testing

Safety and Tolerability of Frovatriptan to Prevention of Menstrually Associated Migraine (MAM) Headaches

Who this might be right for
Migraine
Endo USA Inc., a Keenova Therapeutics Company 550
Not applicableWithdrawnNCT06210672
What this trial is testing

Natural History Study in Patients With LGMDR5/2c

Who this might be right for
Gamma-sarcoglycanopathy
Atamyo Therapeutics
Early research (Phase 1)Active Not RecruitingNCT05973630
What this trial is testing

ATA-200 Gene Therapy Trial in Patients With LGMDR5

Who this might be right for
LGMD2C
Atamyo Therapeutics 4
Not applicableActive Not RecruitingNCT04475926
What this trial is testing

The Natural History of Participants With LGMD2E/R4, LGMD2D/R3, LGMD2C/R5, and LGMD2A/R1 ≥ 4 Years of Age, Who Are Managed in Routine Clinical Practice

Who this might be right for
Limb-girdle Muscular Dystrophy
Sarepta Therapeutics, Inc. 205
Not applicableStudy completedNCT00785005
What this trial is testing

What Makes Exercise Feel More Difficult to Women With and Without Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
University of Colorado, Denver 99
Not applicableStudy completedNCT00786019
What this trial is testing

Influence of Endothelial Function on Central and Peripheral Causes Of Exercise Impairment in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
University of Colorado, Denver 47
Large-scale testing (Phase 3)Study completedNCT02285062
What this trial is testing

Efficacy and Safety Study of Lenalidomide Plus R-CHOP Chemotherapy Versus Placebo Plus R-CHOP Chemotherapy in Untreated ABC Type Diffuse Large B-cell Lymphoma

Who this might be right for
Lymphoma, Large B-Cell, Diffuse
Celgene 570
Not applicableWithdrawnNCT05952388
What this trial is testing

Impact of Clinical Pharmacy Services on Medication Cost and Hospitalization Rates in Hemodialysis Patients

Who this might be right for
End Stage Renal Disease
University of New Mexico